亨斯邁 HUN 深滬

已收盤 09-19 16:00:00 美东时间

9.80

-0.490

-4.76%

華盛通

立即下載

最高10.29
今開10.29
成交量 643.22万股
最低 9.78
昨收 10.29
總市值 17.05亿
52周最高 23.45
市盈率 ^靜 --
換手率 3.70%
52周最低 8.66
委比 -37.55%
總股本 1.74亿
歷史最高 38.10
量比 1.30
振幅 4.96%
歷史最低 -0.27
每手 1
風險率 4.16%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Exxon stops European chemical recycling investments worth more than $100M

Exxon Mobil (NYSE:XOM) said late Wednesday it will pause more than $100M in planned spending for two European chemical recycling projects because of concerns over new draft rules the company believes ...

09-19 03:43
Kairos Pharma Announces Efficacy Data From Ongoing Phase 2 Clinical Trial Of ENV105 In Patients With Metastatic Castration-Resistant Prostate Cancer

Interim efficacy analysis highlights potential value of combination therapy of apalutamide and ENV105 following positive safety dataCompany to host virtual KOL discussion today to provide additional perspective on data

09-18 20:05
这16家中国公司，2025半年玩具收入过亿元

（来源：三文娱）多家上市公司在多元化受挫之后，回归聚焦玩具业务今天（9月17日），量子之歌发布截至2025年6月30日的2025财年第四季度及全年财报。...

09-18 07:53
HUMBL appoints Gregory L. Hopkins as CEO

HUMBL (OTCPK:HMBL) announced on Wednesday that the Board of Directors has appointed Gregory L. Hopkins as CEO. In the public company sector, Hopkins served as senior vice president at Energy Solutions...

09-17 21:08
Huntsman Exploration Forms Advisory Committee, Appoints Tony Ricci

Huntsman Exploration ( ($TSE:HMAN) ) just unveiled an update. Huntsman Explorat...

09-16 00:41
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元

09-15 11:13
瑞穗证券将亨斯迈公司评级从中性下调至跑输大盘后，该公司股价盘前下跌3.2%。

瑞穗证券将亨斯迈公司评级从中性下调至跑输大盘后，该公司股价盘前下跌3.2%。

09-12 18:41
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价

今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元

09-11 10:06
Jefferies Maintains Buy on Huntsman, Lowers Price Target to $14

Jefferies analyst Laurence Alexander maintains Huntsman (NYSE:HUN) with a Buy and lowers the price target from $15 to $14.

09-10 18:55
Serina Therapeutics Secures Up To $20M In Financing To Advance SER-252 Trial In Parkinson's Disease, With Potential For Additional $20M Through Warrant Issuance

Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson's under the 505(b)(2) NDA pathwayEvaluating complementary funding including strategic

09-10 03:25

派息除權日	每股總股息	派息日期
2025-09-15	0.25	2025-09-30
2025-06-13	0.25	2025-06-30
2025-03-14	0.25	2025-03-31
2024-12-13	0.25	2024-12-31
2024-09-13	0.25	2024-09-30
2024-06-14	0.25	2024-06-28
2024-03-14	0.25	2024-03-29
2023-12-14	0.24	2023-12-29
2023-09-14	0.24	2023-09-29
2023-06-14	0.24	2023-06-30
2023-03-14	0.24	2023-03-31
2022-12-14	0.21	2022-12-30
2022-09-14	0.21	2022-09-30
2022-06-14	0.21	2022-06-30
2022-03-14	0.21	2022-03-31
2021-12-14	0.19	2021-12-31
2021-09-14	0.19	2021-09-30
2021-06-14	0.19	2021-06-30
2021-03-12	0.16	2021-03-31
2020-12-14	0.16	2020-12-31
2020-09-14	0.16	2020-09-30
2020-06-12	0.16	2020-06-30
2020-03-12	0.16	2020-03-31
2019-12-12	0.16	2019-12-31
2019-09-12	0.16	2019-09-30
2019-06-13	0.16	2019-06-28
2019-03-14	0.16	2019-03-29
2018-12-13	0.16	2018-12-31
2018-09-13	0.16	2018-09-28
2018-06-14	0.16	2018-06-29
2018-03-14	0.16	2018-03-30
2017-12-14	0.13	2017-12-29
2017-09-14	0.13	2017-09-29
2017-06-13	0.13	2017-06-30
2017-03-13	0.13	2017-03-31
2016-12-13	0.13	2016-12-30
2016-09-13	0.13	2016-09-30
2016-06-13	0.13	2016-06-30
2016-03-11	0.13	2016-03-31
2015-12-11	0.13	2015-12-31
2015-09-11	0.13	2015-09-30
2015-06-11	0.13	2015-06-30
2015-03-12	0.13	2015-03-31
2014-12-11	0.13	2014-12-31
2014-09-18	0.13	2014-09-30
2014-06-12	0.13	2014-06-30
2014-03-12	0.13	2014-03-31
2013-12-12	0.13	2013-12-31
2013-09-19	0.13	2013-09-30
2013-06-12	0.13	2013-06-28
2013-03-13	0.13	2013-03-29
2012-12-12	0.10	2012-12-31
2012-09-12	0.10	2012-09-28
2012-06-13	0.10	2012-06-29
2012-03-13	0.10	2012-03-30
2011-12-13	0.10	2011-12-30
2011-09-13	0.10	2011-09-30
2011-06-13	0.10	2011-06-30
2011-03-11	0.10	2011-03-31
2010-12-13	0.10	2010-12-31
2010-09-13	0.10	2010-09-30
2010-06-11	0.10	2010-06-30
2010-03-11	0.10	2010-03-31
2009-12-11	0.10	2009-12-31
2009-09-11	0.10	2009-09-30
2009-06-11	0.10	2009-06-30
2009-03-12	0.10	2009-03-31
2008-12-11	0.10	2008-12-31
2008-09-11	0.10	2008-09-30
2008-06-12	0.10	2008-06-30
2008-03-12	0.10	2008-03-31
2007-12-12	0.10	2007-12-31
2007-09-12	0.10	2007-09-28
2007-06-13	0.10	2007-06-29
2007-03-13	0.10	2007-03-30

公司名稱	亨斯迈
行業分類	化工产品
業務描述	Huntsman Corp. engages in the manufacturing of differentiated organic chemical products. It operates through the following segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE. The Performance Products segment produces and sells amines, surfactants, LAB, and maleic anhydride to a variety of consumer and industrial end markets. The Advanced Materials segment provides basic liquid and solid epoxy resins, specialty resin compounds, cross linking, matting and curing agents, epoxy, acrylic, and polyurethane based polymer products. The company was founded by Jon Meade Huntsman Sr. in 1970 and is headquartered in The Woodlands, TX.

亨斯邁 HUN 深 滬

9.80

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

亨斯邁 HUN 深滬